A recent study demonstrated that the pattern of cytogenetic changes during clonal evolution remains similar in CML patients treated with or without tyrosine kinase inhibitors (TKIs), supporting the idea of genetic instability induced by BCR-ABL1 as the mechanism of clonal evolution[4]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.